MCLEAN, VA, Affect Therapeutics, reimagining addiction treatment for the digital age, announced a $16 million Series A funding round.
Affect Therapeutics, reimagining addiction treatment for the digital age, announced a $16 million Series A funding round led by ARTIS Ventures, with participation from existing investors, AlleyCorp and CityLight, and participation from new investors, LifeArc Ventures, Samsung Next, and What If Ventures.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
